Presentation
13 March 2024 Molecular imaging and photoimmunotherapy of oral cancers using an EGFR targeted antibody conjugate
Author Affiliations +
Abstract
In this study, we study the influence of dye to antibody ratio on the imaging and therapeutic performance of an EGFR-targeted dual function conjugate. We further demonstrate the efficacy of the conjugate in identifying tumor depth to guide surgical resections and the ability to eliminate residual microscopic disease through photoimmunotherapy, in a single intra-operative setting.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Mohammad A. Saad, Harrison J. Roberts, Isabella Feng, Kaylee Mai, Zhiming Mai, Srivalleesha Mallidi, and Tayyaba Hasan "Molecular imaging and photoimmunotherapy of oral cancers using an EGFR targeted antibody conjugate", Proc. SPIE PC12818, Imaging, Therapeutics, and Advanced Technology in Head and Neck Surgery and Otolaryngology 2024, (13 March 2024); https://doi.org/10.1117/12.3000573
Advertisement
Advertisement
KEYWORDS
Tumors

Antibodies

Cancer

Photoimmunotherapy

Molecular imaging

Dyes

Resection

Back to Top